International Clinical Trial: CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell Transplantation

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07808112) titled 'CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell Transplantation' on Sept. 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Medical College of Wisconsin

Condition: Graft -Versus-host-disease

Intervention: Procedure: Hematopoietic Cell Transplantation Drug: Cyclophosphamide Drug: Tacrolimus Drug: Mycophenolate Mofetil (MMF)

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First E...